    Ellen Strahlman | GlaxoSmithKline plc | ZoomInfo.com










 





BDX Ellen R. Strahlman Insider Trades for Becton Dickinson & Co.


































Bulletin






Investor Alert







New York Markets After Hours



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Becton Dickinson & Co.

                  NYSE: BDX
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Becton Dickinson & Co.



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:52 p.m.


BDX

/quotes/zigman/219467/composite


$
201.98




Change

0.00
0.00%

Volume
Volume 24,121
Quotes are delayed by 20 min








/quotes/zigman/219467/composite
Today's close

$
			201.67
		


$
				201.98
			
Change

+0.31
+0.15%





Day low
Day high
$200.49
$203.19










52 week low
52 week high

            $161.29
        

            $206.63
        


















Insider Activity


Individual




Ellen R. Strahlman



Dr. Ellen R. Strahlman, MD, is Chief Medical Officer, EVP-Research & Development at Becton, Dickinson & Co. She is on the Board of Directors at Losonoco Ltd. and Syncona Partners LLP.
Dr. Strahlman was previously employed as Chief Medical Officer & Senior Vice President by GlaxoSmithKline Plc, Chief Medical Officer & Global Head-Research by Bausch & Lomb, Inc., a Principal by Merck & Co., Inc., a Principal by Novartis Corp., and Vice President-Worldwide Business Development by Pfizer Inc.
She received her undergraduate degree from Harvard University, a graduate degree from the Johns Hopkins Bloomberg School of Public Health, and a doctorate degree from The Johns Hopkins University School of Medicine.



Transactions


Date
Shares
Transaction
Value





11/26/2016
2,120


 
Award at $0 per share.


0


11/26/2016
5,188


 
Derivative/Non-derivative trans. at $0 per share.


0


11/26/2016
6,703


 
Award at $0 per share.


0


05/06/2016
3,019


 
Disposition at $163.52 per share.


493,667


04/22/2016
2,354


 
Derivative/Non-derivative trans. at $159.88 per share.


376,358


11/26/2015
2,129


 
Award at $0 per share.


0


11/25/2014
2,497


 
Award at $0 per share.


0


11/26/2013
2,592


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Vincent A. Forlenza 
Chairman & Chief Executive Officer




Mr. Thomas  Polen 
President




Mr. Christopher R. Reidy 
EVP, Chief Financial & Administrative Officer




Dr. Ellen R. Strahlman 
Chief Medical Officer, EVP-Research & Development




Mr. Aaron  Pettit 
Chief Ethics, Compliance Officer & Senior VP




Ms. Helena  Bragd 
General Manager-Nordisk Region




Mr. David W. Highet 
Chief Intellectual Property Counsel & VP




Mr. Alexandre  Conroy 
President-Europe, EMA & American Region




Mr. Pierre  Boisier 
Senior Vice President-Quality




Mr. Stephen  Sichak 
Senior Vice President-Integrated Supply Chain




Ms. Patti E. Russell 
Senior VP, Chief Ethics & Compliance Officer




Ms. Patricia A. Walesiewicz 
Assistant Secretary




Mr. Gary M. Cohen 
President-Global Health & Executive VP




Mr. John E. Gallagher 
Treasurer, Controller & Senior VP-Finance




Mr. Nabil  Shabshab 
Chief Marketing Officer & EVP-Strategic Planning




Ms. Antoinette F. Segreto 
Vice President-Tax




Mr. Troy  Kirkpatrick 
Head-Media Relations




Ms. Lindsay  Roman 
Senior Manager-Public Relations




Ms. Monique N. Dolecki 
Vice President-Investor Relations




Ms. Linda  Tharby 
Chief Human Resource Officer & Vice President




Mr. Gary M. DeFazio 
Secretary & Senior Vice President




Mr. Richard J. Naples 
Chief Regulatory Officer & Executive VP




Mr. Jeffrey S. Sherman 
Executive Vice President & General Counsel




Mr. R. Andrew  Eckert 
Independent Director




Dr. Claire M. Fraser-Liggett 
Independent Director




Dr. Claire  Pomeroy 
Independent Director




Ms. Catherine M. Burzik 
Independent Director




Ms. Rebecca W. Rimel 
Independent Director




Mr. Christopher Ian Montague Jones 
Independent Director




Mr. Willard J. Overlock 
Independent Director




Mr. Basil L. Anderson 
Independent Director




Mr. James F. Orr 
Independent Director




Mr. Gary A. Mecklenburg 
Independent Director




Mr. Marshall O. Larsen 
Independent Director




Mr. Bertram L. Scott 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




5:59 PM EDT
July 28, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
5:58pWhy it might be time to invest in the companies Amazon is destroying
5:54pBitcoin investors: things may get very ugly soon, if this chart overlay is right
5:44pMeet the ‘Hamilton’ actors who fly cross-country when a cast member can’t go on
5:41pDonald Trump just ousted Reince Priebus. What to do if you think you’re about to get fired
5:38pHere’s what to do if, like Reince Priebus, you’re suddenly out of a job
5:27pReince Priebus departs as chief of staff as Trump gives job to John Kelly
5:25pThe perils (and pleasures) of blocking friends and colleagues on social media
5:12pWhat’s really happening with Target’s Cartwheel app
5:00pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
4:56pBREAKINGIn a tweet, Trump names Gen. Kelly his new chief of staff
4:56pMattel could get wrecked by weak ‘Cars 3’ toy sales
4:55pThis 1 number sums up why that Foxconn deal is over-the-top bad for Wisconsin
4:51pBREAKINGTrump tweets he's named a new chief of staff, John Kelly
4:42pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
4:34pLong-dated Treasury yields see weekly climb 
4:33pS&P 500, Nasdaq finish lower after Amazon disappointment; Dow closes at record
4:32pThe highest paid athletes in the world, in one chart
4:32pHow to raise your kids to be frugal (but not too frugal)
4:31pCities to move to if you want to work in tech — NOT including San Francisco
4:31pWhat Donald Trump’s battle of wills with Jeff Sessions teaches you about a difficult boss
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































 












Ellen Strahlman, Becton, Dickinson & Company Chief Medical Officer & EVP, Research & Development - REDBOOKS








































Brands, Marketers, Agencies. Search Less. Sell More.





/   SIGN IN

GET A FREE TRIAL   
CONTACT US: (800) 908-5395





















Ellen  Strahlman
Chief Medical Officer & EVP, Research & Development, Becton, Dickinson & Company

EMAIL: 
                      







              Real-time sales trigger feed - generated by REDBOOKS machine learning and natural language processing technology, tracking 800,000+ news sources to aggregate all new executives, job/role changes and news on decision makers, brands and agencies in the media/marketing industry.
              

              This sales feed is for Ellen  Strahlman at Becton, Dickinson & Company. Ellen  Strahlman works as Chief Medical Officer & EVP, Research & Development , acting in a Data/Privacy role .  Becton, Dickinson & Company is a leader in Pharmaceuticals & Health Care Products .
              REDBOOKS tracks personnel changes for advertisers spending over $1 million annually.
              

              For more Data/Privacy leads or media/marketing prospecting automation, start a free trial now.
              

Recent Related News


03/13/2017:


GCMI Launches New Medtech Accelerator

..... Selected accelerator companies will live at GCMI for 6 to 12 months depending on the milestones created at admission and the tasks to be completed during their stay. 
“In spite of best efforts, medtech startups still face ‘a valley of death’ when it comes to securing funding and bringing the first product to market”, stated Ellen Strahlman, MD, MHSc, Executive Vice President R&D and Chief Medical Officer for BD. “GCMI represents a unique way to address that issue and the program dovetails nicely with BD’s global accelerator partnerships......

People In This Article:
Ellen Strahlman
 

12/19/2016:


BACIT : Change of Name

..... The ISIN and SEDOL numbers for the ordinary shares will remain unchanged. In addition, the Company is pleased to announce that the appointment of Nigel Keen and Ellen Strahlman as non-executive directors of the Company is effective today. Nigel Keen currently acts as director of Deltex Medical Group plc and has previously acted as director of Bioquell plc, Laird plc and Oxford Instruments plc. .....

People In This Article:
Ellen Strahlman
 






Learn more about Ellen  Strahlman  and 260,000+ key contacts

  Create targeted lead lists

  Gain insider knowledge with advanced machine  learning
  Real-time verified contact info



Enter Work Email:

Please enter email address.
 Please enter valid email address.









             Learn more about Ellen  Strahlman and 260,000+ key contacts
            



























First Name *

 Please enter first name.




Last Name *

 Please enter last name.






Company Name *

 Please enter company name.






Email *





Phone *

 Please enter phone number.
 Please enter 10 digits number.





What industry are you in? *  
                (Please select one the categories below)
Please enter value for the industry.




                     Media Sales
                  




                     Production
                  




                     Ad-Tech/Mar-Tech
                  




                     Sponsorship Sales
                  



  Agency New Business
                  



  Other:
                  




What is your role? *
                 
                 (Please select one the categories below)
Please enter value for the role.



  C-Suite
                  



  VP/Manager
                  



  Sales Rep
                  



  Other:
                  














Thank you for registering for a Free REDBOOKS.com Trial!
We are processing your request and will be in touch shortly to get you started!
For Immediate Assistance, please call us at (800) 908-5395 or email us at info@redbooks.com


























Home
Learn More
FREE Trial


Features




AD THINK Events
Thought Leadership Events
Top Advertiser Directory
Top Agency Directory



Add Your Agency
Update Your Agency
Agency Showcase
Advertising Associations
Creative Spotlight
Services and Suppliers


About Us
Blog
Contact Us
Jobs
Terms & Conditions
Privacy Policy





Customer Support
(800) 908-5395
Connect with us




















Copyright © 2017 Red Books LLC. All rights reserved
































Ellen Strahlman, MD, MHSc - OIS





















































































Ellen Strahlman, MD, MHSc
Chief Medical Officer
Becton, Dickinson and Company
Back to previous page


Biography

Dr Ellen Strahlman is currently Chief Medical Officer for Becton, Dickinson and Company.
She was previously Senior Vice President, Office of the CEO, and Global Head, Neglected Tropical Diseases for GlaxoSmithKline. In this capacity, she led the company’s many programs and activities in Global Health, served on the Board of Directors for ViiV Healthcare, plc, was the Senior Executive Advisor to the CEO Future Strategy Group, Vaccines Public Health Program and PULSE Volunteer Program, and provided specific support to the CEO for medical matters relating to public health, access to medicine programs, corporate development activities, and other external engagement efforts.
Ellen joined GSK in August 2008, as the Chief Medical Officer for the company. In this role, as the most senior physician leader of the company, she had primary responsibility for matters of patient safety, general medical governance, medical ethics and integrity, medical information, and investigations involving human subjects relating to any GSK product (pharmaceutical, biological and consumer healthcare medicinal products) in development and on the market. She was appointed to her new role in the Office of the CEO in March 2012. Prior to joining GSK, Ellen was Vice President, Worldwide Business Development at Pfizer. Earlier in her career, Ellen held senior leadership positions at Bausch & Lomb, Merck & Co. and, more recently, at Novartis and Virgoen Ltd.
Accompanying her work in industry, Ellen has been a champion and spokesperson for public health and world heath issues, including HIV and blinding eye diseases. She is a graduate of Harvard University (Biochemical Sciences and Applied Mathematics) and obtained her medical degree from the Johns Hopkins School of Medicine. She has medical qualifications in general surgery and ophthalmology, together with a Masters Degree in Health Sciences.
Latest News
Double Shot Gives Spark Therapeutics a JoltInotek May Be for Sale, But Who Will Buy?
 
About OIS
Events
News
Videos
OIS Podcast
OIS Index
Contact Us

Call Us: 516-765-9005

 GET INVOLVED
Sponsorship Opportunities
Presenting Companies
Companies to Watch
Media & Press
Advertise with OIS
Be Our Podcast Guest


Upcoming Events
OIS@ASRS 2017 
OIS@AAO 2017 

Connect With Us
FacebookGoogle+LinkedinTwitterYouTube




https://www.googletagmanager.com/ns.html?id=GTM-TDTW6F4"
height="0" width="0" style="display:none;visibility:hidden">







 













Ellen Strahlman | The BMJ
























Skip to main content


    This site uses cookies. More info
Close
By continuing to browse the site you are agreeing to our use of cookies. Find out more here
Close














Subscribe




    My Account    

My email alerts



BMA member login



    Login    




Username *



Password *



Forgot your sign in details? 


Need to activate 




BMA members 


Sign in via OpenAthens 


Sign in via your institution 











Edition: 


    US    

UK
South Asia
International






 




Our company












Toggle navigation




The BMJ logo

Site map




Search






Search form
SearchSearch




 




Advanced search
Search responses
Search blogs









Toggle top menu













 










Ellen Strahlman




Ellen Strahlman, M.D., M.H.Sc., is the Executive Vice President for Research and Development and Chief Medical Officer for BD (Becton, Dickinson and Company). In this role, she oversees the Company’s Innovation System, Research & Development (R&D) and Medical Affairs functions. As an Officer of the Company, she is the MC Co-Chair of the Science, Marketing, Innovation and Technology Committee for the BD Board of Directors; and she serves as a member of the Company’s Management Committee (MC), Corporate Business Development Team, Corporate Ethics Steering Team, and the BD Leadership Team. In her Management capacity, Ellen Co-Chairs the company’s Innovation and New Product Development Council, Chairs the R&D and the Medical Affairs Leadership Teams and leads the Office of Science, Medicine & Technology for BD, comprising more than 3500 associates worldwide. 
Dr. Strahlman joined BD in May 2013, from GlaxoSmithKline , having served as the Senior Vice President and Chief Medical Officer since 2008 in addition to working in the Office of the CEO as Senior Medical Advisor and Global Head of Neglected Tropical Diseases. As GSK’s Chief Medical Officer, Dr. Strahlman had accountability for medical safety and patient matters for all programs in development and commercialized products in the Vaccines, Pharmaceutical and Consumer businesses, as well as organizational responsibility for activities that included medical affairs, regulatory affairs, clinical safety and other areas. Prior to GlaxoSmithKline, Dr. Strahlman held executive leadership roles at Merck, Novartis, Pfizer, and Bausch & Lomb that included oversight of the development, licensing and commercialization of proprietary and generic pharmaceuticals, vaccines, drug delivery systems, consumer products and medical devices. 
Throughout her career, Ellen has, and continues to be, a passionate advocate for the democratization of technology and access to high-quality healthcare and has worked to create business solutions designed to deliver medicines, products and services on a global basis. . She currently serves on the Board of Directors for Sycona Partners LLP, the Advisory Boards for the British Medical Journal and the Johns Hopkins Bloomberg School of Public Health, Health Advisory Board, and in November 2012, she became a Fellow of the Salzburg Global Seminars, a non-profit organization that holds seminars that strive to "challenge present and future leaders to solve issues of global concern. Past roles include serving on the Board of Directors for ViiV Healthcare plc, Industry Representative on the FDA/CDER Dermatologic & Ophthalmic Drug Advisory Committee, WHO Partnership for Disease Control Initiatives, UN Commission on Life-Saving Commodities for Women & Children and the Healthcare Coalition for the International Centre for Missing & Exploited Children.  
Ellen is a graduate of Harvard University (Biochemical Sciences) and obtained her medical degree from the Johns Hopkins School of Medicine.  She has medical qualifications in general surgery (Johns Hopkins) and ophthalmology (the Wilmer Institute, Johns Hopkins). Finally, Ellen earned her Masters Degree in Health Sciences from the Johns Hopkins Bloomberg School of Public Health as a Carnegie-Mellon Physician Public Health Fellow. 
See Ellen Strahlman's declaration of interests form
 





 





 




This week's poll







Read related article
See previous polls









 





 







 


 
 
























Ellen Strahlman





































Skip NavigationAbout Dean SearchSchool At a GlanceBloomberg American Health InitiativeHistoryCentennialWhat is Public HealthDean Klag's CornerFaculty DirectoryLecture SeriesHonors & AwardsSchool-Wide InitiativesOffices & ServicesDirections & MapsEvent CalendarCareersContact UsAcademics Degree ProgramsCertificate ProgramsContinuing & Executive EducationOnline Learning & CoursesOpenCourseWareResidency ProgramsPostdoctoral TrainingCourse CatalogAcademic CalendarFaculty DirectoryFaculty Recognition Lecture SeriesOffice of Academic AffairsAdmissions How to ApplyInternational ApplicantsTuition & FeesFinancial AidFunding OpportunitiesFunding ResourcesScholarshipsVisitConnect with Current StudentsConnect with FacultyMeet JHSPH in Your AreaContact AdmissionsDepartments Biochemistry and Molecular BiologyBiostatisticsEnvironmental Health and EngineeringEpidemiologyHealth, Behavior and SocietyHealth Policy and ManagementInternational HealthMental HealthW. Harry Feinstone Dept of Molecular Microbiology and ImmunologyPopulation, Family and Reproductive HealthResearch Centers & InstitutesGlobal ProjectsInstitutional Review BoardFaculty DirectorySciVal Experts Research ProfilesSciVal FundingStudent Life Events & ActivitiesHousingDiningFitness CenterInternational StudentsCareer ServicesVisitLife in BaltimoreOffice of Student LifeStudent AssemblySOURCE (Student Outreach Resource Center)SustainabilityTransportationGraduationOffice of Student AffairsPractice & Training Practice for FacultyPractice for StudentsPractice for ProfessionalsContinuing EducationContact UsOnline TrainingsGraduate Training Programs in Clinical InvestigationMid‑Atlantic Regional Public Health Training CenterNews About UsNews ReleasesStoriesSocial MediaGiving Make a GiftHow Your Gift HelpsDonor StoriesRising to the ChallengeContact UsFAQs



Search Terms



Search











Johns Hopkins Bloomberg School of Public Health Protecting Health, Saving Lives—Millions at a TimeHealth Advisory Board


Home


Overview


Board Members

Committee Structure


Philanthropic Impact


Office Directory


Members Only


 IN MEMORIAM: D.A. HENDERSON1928 - 2016Home > About > School at a Glance > Health Advisory Board > Board Members > Ellen Strahlman  Ellen Strahlman, MD, MHSc Senior Vice President, Research & Development Chief Medical OfficerEllen Strahlman, MD, MHSc, is a senior executive with 23 years of international experience in the healthcare industry (biopharmaceuticals, medical devices, public health).  She is currently the Senior Vice President, Research & Development and Chief Medical Officer and for Becton, Dickinson and Company, a leading global medical technology company.Dr Strahlman reports to BD’s CEO, Vincent Forlenza, and has accountability for the Company’s Innovation System as well as R&D and Medical Affairs functions.  As an Officer of the Company, she serves on the CEO’s Management Committee, Worldwide Operating Committee, the BD Leadership Team, Corporate Business Development Team, Corporate Ethics Steering Team and CenterPoint Steering Team.   In her Management capacity, she Co-Chairs the company’s Innovation Council, Chairs the R&D Management Committee and the Medical Affairs Leadership Team and leads the newly established Office of Science, Medicine & Technology for BD.Dr. Strahlman joined BD in May 2013 from GlaxoSmithKline, plc, having served as the Senior Vice President and Chief Medical Officer (CMO) since 2008 and also working in the Office of the CEO as Senior Medical Advisor and Global Head of Neglected Tropical Diseases.  As GSK’s CMO, Dr. Strahlman had accountability for medical safety and patient matters for development programs and commercialized products in the Vaccines, Pharmaceutical and Consumer businesses, as well as organizational oversight for activities that included medical affairs, product development, clinical safety and pharmacovigilance, regulatory affairs, quality and compliance.   Known for her scientific and patient-centric leadership across the continuum of product ideation, development and commercialization, Dr. Strahlman has led teams developing pharmaceuticals, medical devices, generics and consumer products in nearly every therapeutic category since 1991.  She has served at the executive level in roles leading R&D, Medical Affairs, Scientific Affairs, and Business Development organizations. Her executive experience includes leadership roles at Merck, Bausch & Lomb, Novartis, Pfizer, and GSK; and she has also worked as a biotech CEO.Throughout her career, Ellen has, and continues to be, a passionate advocate for global heath and has worked to create business solutions designed to deliver equitable global access to high-quality healthcare services.  Well-versed in global health and international policy, Ellen has served as corporate liaison to the press, media and government agencies on a variety of medical and healthcare system related issues. As a spokesperson for the industry and biotechnology, she has addressed issues of public health and corporate social responsibility in the healthcare industrial sector. Ellen is a graduate of Harvard University (Biochemical Sciences) and obtained her medical degree from the Johns Hopkins School of Medicine.  She has medical qualifications in general surgery (Johns Hopkins) and ophthalmology (the Wilmer Institute, Johns Hopkins). Finally, Ellen earned her Masters Degree in Health Sciences from the Johns Hopkins Bloomberg School of Public Health as a Carnegie-Mellon Physician Public Health Fellow.Johns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street, Baltimore, MD 21205Contact Us Directions & Maps Calendars Offices & Services Online Learning & Courses Careers Accreditation Web Policies FeedbackJHSPH Alumni my.jhsph.edu CoursePlus Student Information System (SIS) my.jhu.eduLike Us on Facebook Follow Us on Twitter Watch Videos on YouTube Follow us on Instagram Connect with LinkedInJohns Hopkins University





Ellen Strahlman, MD MHSc | Exponential Medicine | November 2017



































































































Navigation



Exponential Medicine | November 2017
Exponential Medicine | November 2017


 










Ellen Strahlman, MD MHSc 













 



Ellen Strahlman, MD MHSc





Chief Medical Officer, Becton Dickinson
 






 



 
 



 
 
 




Ellen Strahlman, M.D., M.H.Sc., is the Executive Vice President for Research and Development and Chief Medical Officer for BD. In this role, she oversees BD's Innovation System, and the R&D and Medical Affairs functions. As an Executive Officer of the Company, she Co-Chairs the Science, Marketing, Innovation and Technology Committee for the BD Board of Directors; Co-Chairs BD's Innovation and New Product Development Council, and she leads the Office of Science, Medicine & Technology for BD, comprising more than 3500 associates worldwide. 
Throughout her career, Ellen has, and continues to be, a passionate advocate for “innovation and access” in the healthcare industry, leading teams that provide the democratization of technology and access to high-quality healthcare. She has worked to create business solutions designed to deliver medicines, products and services on a global basis.
Dr. Strahlman joined BD in May 2013, from GlaxoSmithKline , having served as the Senior Vice President and Chief Medical Officer since 2008. As GSK’s Chief Medical Officer, Dr. Strahlman had accountability for medical safety and patient matters for all programs in development and commercialized products in the Vaccines, Pharmaceutical and Consumer businesses. Prior to GlaxoSmithKline, Dr. Strahlman held executive leadership roles at Merck, Novartis, Pfizer, and Bausch & Lomb. 
She currently serves on the Board of Directors for Syncona Partners LLP, Advisory Boards for the British Medical Journal and the Johns Hopkins Bloomberg School of Public Health, and is a Fellow of the Salzburg Global Seminars. 
Ellen is a graduate of Harvard University and the Johns Hopkins School of Medicine. She has medical qualifications in general surgery (Johns Hopkins) and ophthalmology (the Wilmer Institute, Johns Hopkins). Finally, Ellen earned her Masters Degree in Health Sciences from the Johns Hopkins Bloomberg School of Public Health as a Carnegie-Mellon Physician Public Health Fellow. 
 
 
 









 





View More Exponential Medicine Faculty
Exponential Medicine brings together top experts to inform medical leaders how technology is impacting business. View the full list of 2016 faculty:





View All Faculty



 
 
 


 


 








 CONTACT US
For press inquires, partnerships, or for general inquiries, contact us.
For group sale information, contact group sales.
 

 
PLATINUM PARTNER


Platinum Partner of Singularity University Summits
 




































 

